Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.09.028Source: DataRank Database

Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers is a research paper published in Transplantation and Cellular Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.95)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Caroline Diorio ORCID,Colleen Annesley ORCID,Rebecca Gardner ORCID,Andrea K. Graham ORCID,L. Nelson Sanchez‐Pinto ORCID

Live enrichment

PubMed:41038347 PMC:PMC12823210 OpenAlex:https://openalex.org/W4414811821

National Institutes of Health National Cancer Institute

Grant: ZIA BC 012187

National Center for Advancing Translational Sciences

Grant: K12TR005104

U.S. Department of Health and Human Services

Clinical Center

Leukemia and Lymphoma Society

National Institutes of Health

FWCI

2.95

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12823210/

publisherhttps://api.elsevier.com/content/article/PII:S2666636725014526?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636725014526?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtct.2025.09.028

Fields of Study

CAR-T cell therapy researchBiosimilars and Bioanalytical MethodsHumansImmunotherapy, AdoptiveChildReceptors, Chimeric AntigenSurveys and QuestionnairesInflammationT-LymphocytesAntibodies, Monoclonal, HumanizedAdolescent

MeSH Terms

Receptors, Chimeric AntigenAdolescentChildHumansInflammationSurveys and QuestionnairesT-LymphocytesImmunotherapy, AdoptiveAntibodies, Monoclonal, Humanized

Keywords

Chimeric antigen receptorTocilizumabAdverse effectCytokine release syndromeRefractory (planetary science)ToxicityPharmacovigilanceCompassionate UseImmunotherapyImmune-related Adverse EventsChimeric Antigen Receptor T-cell TherapyImmune Effector-cell-associated Neurotoxicity Syndrome, Survey, Pediatric

Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers

FAIR Checklist

Authors (12)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)